Search results
Dusty 'Cat's Paw Nebula' contains a type of molecule never seen in space — and it's one of the...
LiveScience· 2 days agoResearchers have detected an unusually large, previously undetected molecule in the Cat's Paw...
Study finds network of inflammatory molecules may act as biomarker for risk of future...
Medical Xpress· 1 day agoThe study, published in the journal Stroke, has found that measuring concentrations of a network of...
Here's Why Eli Lilly Stock Remains a Screaming Buy
Motley Fool via Yahoo Finance· 4 hours agoLilly has DACRA QW II in phase 1 testing. Chief Scientific Officer Dan Skovronksy said in the Q1 call that the company is "excited about the portfolio of...
Remix Therapeutics Announces First Patients Dosed in Two Phase 1 Clinical Trials Investigating...
WFRV 5 Green Bay· 3 hours agoRemix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers of disease ...
Newly Spotted Complex Molecule Is Among The Largest Ever Discovered Outside The Solar System
IFLScience· 3 days agoAstronomers have discovered a complex molecule in a star-forming region known as the Cat’s Paw...
Another New Molecule Discovered Forming in Space
Universe Today· 3 days agoThe list of chemicals found in space is growing longer and longer. The new chemical is known as 2-methoxyethanol (CH3OCH2CH2OH). It’s one of several...
Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with...
NBC 17 Raleigh· 2 hours agoPalatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin ...
BridgeBio taps VCs for $200M, fueling oncology spinout's push to surpass KRAS class
FierceBiotech· 3 hours agoBridgeBio Pharma has spun its Rolodex to fund a subset of its sprawling list of opportunities. Busy...
Project Optimus: helping or hindering cancer drug development?
Clinical Trials Arena via Yahoo Finance· 6 hours agoHowever, development has historically prioritised drug efficacy and eliminating the tumour and...
Agios Pharmaceuticals Reports Q1 2024 Earnings: Narrower Loss than Expected with Strong Revenue ...
GuruFocus.com via Yahoo Finance· 1 hour agoThis performance is notably better than analyst expectations, which had projected a higher loss of...
